Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

A new risk score for patients after first recurrence of stage 4 neuroblastoma aged ≥18 months at first diagnosis.

Kreitz K, Ernst A, Schmidt R, Simon T, Fischer M, Volland R, Hero B, Berthold F.

Cancer Med. 2019 Dec;8(17):7236-7243. doi: 10.1002/cam4.2562. Epub 2019 Oct 20.

2.

[120-day follow-up after proximal femoral fractures-first results from the Geriatric Trauma Registry DGU®].

Schoeneberg C, Knobe M, Babst R, Friess T, Volland R, Hartwig E, Schmidt W, Lendemans S, Buecking B; AltersTraumaRegister DGU.

Unfallchirurg. 2019 Oct 9. doi: 10.1007/s00113-019-00730-4. [Epub ahead of print] German.

PMID:
31598740
3.

Correction to: Evaluation of new quality indicators for the TraumaRegister DGU® using the systematic QUALIFY methodology.

Bieler D, Hörster A, Lefering R, Franke A, Waydhas C, Huber-Wagner S, Baacke M, Paffrath T, Wnent J, Volland R, Jakisch B, Walcher F, Kulla M.

Eur J Trauma Emerg Surg. 2019 Apr 29. doi: 10.1007/s00068-019-01135-z. [Epub ahead of print]

PMID:
31037352
4.

Evaluation of new quality indicators for the TraumaRegister DGU® using the systematic QUALIFY methodology.

Bieler D, Hörster A, Lefering R, Franke A, Waydhas C, Huber-Wagner S, Baacke M, Paffrath T, Wnent J, Volland R, Jakisch B, Walcher F, Kulla M.

Eur J Trauma Emerg Surg. 2018 Dec 14. doi: 10.1007/s00068-018-1055-z. [Epub ahead of print] Erratum in: Eur J Trauma Emerg Surg. 2019 Apr 29;:.

PMID:
30552453
5.

A mechanistic classification of clinical phenotypes in neuroblastoma.

Ackermann S, Cartolano M, Hero B, Welte A, Kahlert Y, Roderwieser A, Bartenhagen C, Walter E, Gecht J, Kerschke L, Volland R, Menon R, Heuckmann JM, Gartlgruber M, Hartlieb S, Henrich KO, Okonechnikov K, Altmüller J, Nürnberg P, Lefever S, de Wilde B, Sand F, Ikram F, Rosswog C, Fischer J, Theissen J, Hertwig F, Singhi AD, Simon T, Vogel W, Perner S, Krug B, Schmidt M, Rahmann S, Achter V, Lang U, Vokuhl C, Ortmann M, Büttner R, Eggert A, Speleman F, O'Sullivan RJ, Thomas RK, Berthold F, Vandesompele J, Schramm A, Westermann F, Schulte JH, Peifer M, Fischer M.

Science. 2018 Dec 7;362(6419):1165-1170. doi: 10.1126/science.aat6768.

PMID:
30523111
6.

[Data content of the TraumaRegister DGU® : Results of a random sample control].

Ziprian T, Laue F, Ramadanov N, Nienaber U, Volland R, Lefering R, Matthes G.

Unfallchirurg. 2018 Oct;121(10):802-809. doi: 10.1007/s00113-018-0554-z. Review. German.

PMID:
30242445
7.

Reproductive Performance after Unilateral or Bilateral Oviduct Transfer of 2-Cell Embryos in Mice.

Mahabir E, Volland R, Landsberger A, Manz S, Na E, Urban I, Michel G.

J Am Assoc Lab Anim Sci. 2018 Mar 1;57(2):110-114.

8.

Sense-Antisense lncRNA Pair Encoded by Locus 6p22.3 Determines Neuroblastoma Susceptibility via the USP36-CHD7-SOX9 Regulatory Axis.

Mondal T, Juvvuna PK, Kirkeby A, Mitra S, Kosalai ST, Traxler L, Hertwig F, Wernig-Zorc S, Miranda C, Deland L, Volland R, Bartenhagen C, Bartsch D, Bandaru S, Engesser A, Subhash S, Martinsson T, Carén H, Akyürek LM, Kurian L, Kanduri M, Huarte M, Kogner P, Fischer M, Kanduri C.

Cancer Cell. 2018 Mar 12;33(3):417-434.e7. doi: 10.1016/j.ccell.2018.01.020.

9.

Influence of repetitive diving in freshwater on pressure equalization and Eustachian tube function in recreational scuba divers.

Jansen S, Boor M, Meyer MF, Pracht ED, Volland R, Klünter HD, Hüttenbrink KB, Beutner D, Grosheva M.

Diving Hyperb Med. 2017 Dec;47(4):223-227. doi: 10.28920/dhm47.4.223-227.

10.

Repetitive freshwater diving: risk factors and prevalence of barotrauma.

Jansen S, Meyer MF, Boor M, Volland R, Pracht ED, Klünter HD, Hüttenbrink KB, Beutner D, Grosheva M.

Undersea Hyperb Med. 2017 Sept-Oct;44(5):407-414.

PMID:
29116695
11.

Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment.

Rosswog C, Schmidt R, Oberthuer A, Juraeva D, Brors B, Engesser A, Kahlert Y, Volland R, Bartenhagen C, Simon T, Berthold F, Hero B, Faldum A, Fischer M.

Neoplasia. 2017 Dec;19(12):982-990. doi: 10.1016/j.neo.2017.09.006. Epub 2017 Nov 5.

12.

Prenatal parental decision-making and postnatal outcome in renal oligohydramnios.

Mehler K, Gottschalk I, Burgmaier K, Volland R, Büscher AK, Feldkötter M, Keller T, Weber LT, Kribs A, Habbig S.

Pediatr Nephrol. 2018 Apr;33(4):651-659. doi: 10.1007/s00467-017-3812-3. Epub 2017 Oct 27.

PMID:
29075889
13.

Retrospective analysis of relapsed abdominal high-risk neuroblastoma.

Dübbers M, Simon T, Berthold F, Fischer J, Volland R, Hero B, Cernaianu G.

J Pediatr Surg. 2018 Mar;53(3):558-566. doi: 10.1016/j.jpedsurg.2017.09.002. Epub 2017 Sep 11.

PMID:
29021103
14.

Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months.

Fischer J, Pohl A, Volland R, Hero B, Dübbers M, Cernaianu G, Berthold F, von Schweinitz D, Simon T.

BMC Cancer. 2017 Aug 4;17(1):520. doi: 10.1186/s12885-017-3493-0.

15.

Dyslipidemia after pediatric renal transplantation-The impact of immunosuppressive regimens.

Habbig S, Volland R, Krupka K, Querfeld U, Dello Strologo L, Noyan A, Yalcinkaya F, Topaloglu R, Webb NJ, Kemper MJ, Pape L, Bald M, Kranz B, Taylan C, Höcker B, Tönshoff B, Weber LT.

Pediatr Transplant. 2017 May;21(3). doi: 10.1111/petr.12914. Epub 2017 Mar 28.

PMID:
28370750
16.

Lack of immunocytological GD2 expression on neuroblastoma cells in bone marrow at diagnosis, during treatment, and at recurrence.

Schumacher-Kuckelkorn R, Volland R, Gradehandt A, Hero B, Simon T, Berthold F.

Pediatr Blood Cancer. 2017 Jan;64(1):46-56. doi: 10.1002/pbc.26184. Epub 2016 Sep 22.

PMID:
27654028
17.

MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma.

Fabian J, Opitz D, Althoff K, Lodrini M, Hero B, Volland R, Beckers A, de Preter K, Decock A, Patil N, Abba M, Kopp-Schneider A, Astrahantseff K, Wünschel J, Pfeil S, Ercu M, Künkele A, Hu J, Thole T, Schweizer L, Mechtersheimer G, Carter D, Cheung BB, Popanda O, von Deimling A, Koster J, Versteeg R, Schwab M, Marshall GM, Speleman F, Erb U, Zoeller M, Allgayer H, Simon T, Fischer M, Kulozik AE, Eggert A, Witt O, Schulte JH, Deubzer HE.

Oncotarget. 2016 Oct 11;7(41):66344-66359. doi: 10.18632/oncotarget.11662.

18.

Extrarenal Manifestations in Shigatoxin-associated Haemolytic Uremic Syndrome.

Matthies J, Hünseler C, Ehren R, Volland R, Körber F, Hoppe B, Weber LT, Habbig S.

Klin Padiatr. 2016 Jul;228(4):181-8. doi: 10.1055/s-0042-108444. Epub 2016 Jun 13.

PMID:
27294341
19.

Lack of transmission of murine norovirus to mice via in vitro fertilization, intracytoplasmic sperm injection, and ovary transplantation.

Raspa M, Mahabir E, Fray M, Volland R, Scavizzi F.

Theriogenology. 2016 Jul 15;86(2):579-88. doi: 10.1016/j.theriogenology.2016.02.008. Epub 2016 Feb 18.

PMID:
26972226
20.

Boolean modeling identifies Greatwall/MASTL as an important regulator in the AURKA network of neuroblastoma.

Dahlhaus M, Burkovski A, Hertwig F, Mussel C, Volland R, Fischer M, Debatin KM, Kestler HA, Beltinger C.

Cancer Lett. 2016 Feb 1;371(1):79-89. doi: 10.1016/j.canlet.2015.11.025. Epub 2015 Nov 23.

PMID:
26616283
21.

Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma.

Ikram F, Ackermann S, Kahlert Y, Volland R, Roels F, Engesser A, Hertwig F, Kocak H, Hero B, Dreidax D, Henrich KO, Berthold F, Nürnberg P, Westermann F, Fischer M.

Mol Oncol. 2016 Feb;10(2):344-59. doi: 10.1016/j.molonc.2015.10.020. Epub 2015 Nov 7.

22.

The number of removed lymph nodes by inguinofemoral lymphadenectomy: impact on recurrence rates in patients with vulva carcinoma.

Diehl A, Volland R, Kirn V, Thangarajah F, Eichler C, Einzmann T, Wirtz M, Ratiu D, Morgenstern B, Fridrich C, Mallmann P, Puppe J.

Arch Gynecol Obstet. 2016 Jul;294(1):131-6. doi: 10.1007/s00404-015-3932-6. Epub 2015 Oct 26.

PMID:
26498758
23.

Telomerase activation by genomic rearrangements in high-risk neuroblastoma.

Peifer M, Hertwig F, Roels F, Dreidax D, Gartlgruber M, Menon R, Krämer A, Roncaioli JL, Sand F, Heuckmann JM, Ikram F, Schmidt R, Ackermann S, Engesser A, Kahlert Y, Vogel W, Altmüller J, Nürnberg P, Thierry-Mieg J, Thierry-Mieg D, Mariappan A, Heynck S, Mariotti E, Henrich KO, Gloeckner C, Bosco G, Leuschner I, Schweiger MR, Savelyeva L, Watkins SC, Shao C, Bell E, Höfer T, Achter V, Lang U, Theissen J, Volland R, Saadati M, Eggert A, de Wilde B, Berthold F, Peng Z, Zhao C, Shi L, Ortmann M, Büttner R, Perner S, Hero B, Schramm A, Schulte JH, Herrmann C, O'Sullivan RJ, Westermann F, Thomas RK, Fischer M.

Nature. 2015 Oct 29;526(7575):700-4. doi: 10.1038/nature14980. Epub 2015 Oct 14.

24.

Comparison of RNA-seq and microarray-based models for clinical endpoint prediction.

Zhang W, Yu Y, Hertwig F, Thierry-Mieg J, Zhang W, Thierry-Mieg D, Wang J, Furlanello C, Devanarayan V, Cheng J, Deng Y, Hero B, Hong H, Jia M, Li L, Lin SM, Nikolsky Y, Oberthuer A, Qing T, Su Z, Volland R, Wang C, Wang MD, Ai J, Albanese D, Asgharzadeh S, Avigad S, Bao W, Bessarabova M, Brilliant MH, Brors B, Chierici M, Chu TM, Zhang J, Grundy RG, He MM, Hebbring S, Kaufman HL, Lababidi S, Lancashire LJ, Li Y, Lu XX, Luo H, Ma X, Ning B, Noguera R, Peifer M, Phan JH, Roels F, Rosswog C, Shao S, Shen J, Theissen J, Tonini GP, Vandesompele J, Wu PY, Xiao W, Xu J, Xu W, Xuan J, Yang Y, Ye Z, Dong Z, Zhang KK, Yin Y, Zhao C, Zheng Y, Wolfinger RD, Shi T, Malkas LH, Berthold F, Wang J, Tong W, Shi L, Peng Z, Fischer M.

Genome Biol. 2015 Jun 25;16:133. doi: 10.1186/s13059-015-0694-1.

25.

Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers.

Oberthuer A, Juraeva D, Hero B, Volland R, Sterz C, Schmidt R, Faldum A, Kahlert Y, Engesser A, Asgharzadeh S, Seeger R, Ohira M, Nakagawara A, Scaruffi P, Tonini GP, Janoueix-Lerosey I, Delattre O, Schleiermacher G, Vandesompele J, Speleman F, Noguera R, Piqueras M, Bénard J, Valent A, Avigad S, Yaniv I, Grundy RG, Ortmann M, Shao C, Schwab M, Eils R, Simon T, Theissen J, Berthold F, Westermann F, Brors B, Fischer M.

Clin Cancer Res. 2015 Apr 15;21(8):1904-15. doi: 10.1158/1078-0432.CCR-14-0817. Epub 2014 Sep 17.

26.

Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastoma.

Theissen J, Oberthuer A, Hombach A, Volland R, Hertwig F, Fischer M, Spitz R, Zapatka M, Brors B, Ortmann M, Simon T, Hero B, Berthold F.

Genes Chromosomes Cancer. 2014 Aug;53(8):639-49. doi: 10.1002/gcc.22174. Epub 2014 Apr 15.

PMID:
24737690
27.

Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice.

Hoyer-Kuhn H, Kohbrok S, Volland R, Franklin J, Hero B, Beck BB, Hoppe B.

Clin J Am Soc Nephrol. 2014 Mar;9(3):468-77. doi: 10.2215/CJN.06820613. Epub 2014 Jan 2.

28.

Iodine-123 metaiodobenzylguanidine scintigraphy scoring allows prediction of outcome in patients with stage 4 neuroblastoma: results of the Cologne interscore comparison study.

Decarolis B, Schneider C, Hero B, Simon T, Volland R, Roels F, Dietlein M, Berthold F, Schmidt M.

J Clin Oncol. 2013 Mar 1;31(7):944-51. doi: 10.1200/JCO.2012.45.8794. Epub 2013 Jan 22.

PMID:
23341514
29.
30.

[Blood collection from central venous catheter--valid also for blood coagulation analysis?].

Werner W, Krohn K, Hummel L, Volland R.

Zentralbl Chir. 1996;121(1):58-60. German.

PMID:
8852742
31.

[7-ethoxycoumarin o-deethylase and fibrosis in chronic liver diseases].

Truckenbrodt J, Müller A, Kraul H, Machnik G, Volland R, Reinhardt M, Hoffmann A.

Gastroenterol J. 1991;51(1):15-7. German.

PMID:
1654926
32.

Studies on the in-vitro biotransformation in patients with liver diseases.

Truckenbrodt J, Kraul H, Machnik G, Volland R, Hoffmann A.

Gastroenterol J. 1989;49(3):126-8.

PMID:
2629781

Supplemental Content

Loading ...
Support Center